thromboplastin and Testicular-Neoplasms

thromboplastin has been researched along with Testicular-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for thromboplastin and Testicular-Neoplasms

Article	Year
Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients. Thrombosis research, 2013, Volume: 131, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell-Derived Microparticles; Cisplatin; Etoposide; Humans; Male; Neoplasm Metastasis; Testicular Neoplasms; Thromboplastin	2013
Effect of tissue factor deficiency on mouse and tumor development. Proceedings of the National Academy of Sciences of the United States of America, 1997, Jun-24, Volume: 94, Issue:13 Previous reports suggest that tissue factor (TF) may play an essential role in embryonic vascular development and tumor angiogenesis. To further examine this relationship, the morphology of fully developed TF-deficient embryos and the growth of TF-deficient teratomas and teratocarcinomas were analyzed. In a 129/Sv genetic background, TF null embryos do not survive beyond mid-gestation. In contrast, 14% of 129/Sv x C57BL/6 TF-deficient embryos escape this early mortality and survive to birth. On gross and microscopic inspection, these late gestation, TF-deficient embryos appear normal. The growth and vascularity of TF(+/+), TF(+/-), and TF(-/-) teratomas and teratocarcinomas are indistinguishable. Thus, tumor-derived TF is not required for tumor growth and angiogenesis and the combined data do not support an essential role for TF in embryonic vascular development. Topics: Animals; Embryonic and Fetal Development; Female; Gene Deletion; Gene Expression Regulation, Developmental; Male; Mice; Mice, Inbred C57BL; Pregnancy; Teratocarcinoma; Teratoma; Testicular Neoplasms; Thromboplastin	1997

Article

Year

Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients.

Thrombosis research, 2013, Volume: 131, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell-Derived Microparticles; Cisplatin; Etoposide; Humans; Male; Neoplasm Metastasis; Testicular Neoplasms; Thromboplastin

2013

Effect of tissue factor deficiency on mouse and tumor development.

Proceedings of the National Academy of Sciences of the United States of America, 1997, Jun-24, Volume: 94, Issue:13

Previous reports suggest that tissue factor (TF) may play an essential role in embryonic vascular development and tumor angiogenesis. To further examine this relationship, the morphology of fully developed TF-deficient embryos and the growth of TF-deficient teratomas and teratocarcinomas were analyzed. In a 129/Sv genetic background, TF null embryos do not survive beyond mid-gestation. In contrast, 14% of 129/Sv x C57BL/6 TF-deficient embryos escape this early mortality and survive to birth. On gross and microscopic inspection, these late gestation, TF-deficient embryos appear normal. The growth and vascularity of TF(+/+), TF(+/-), and TF(-/-) teratomas and teratocarcinomas are indistinguishable. Thus, tumor-derived TF is not required for tumor growth and angiogenesis and the combined data do not support an essential role for TF in embryonic vascular development.

Topics: Animals; Embryonic and Fetal Development; Female; Gene Deletion; Gene Expression Regulation, Developmental; Male; Mice; Mice, Inbred C57BL; Pregnancy; Teratocarcinoma; Teratoma; Testicular Neoplasms; Thromboplastin

1997